Germany and other funders pledge support to GARDP to ramp up efforts in countering antibiotic resistance
19 October 2022
The German Federal Ministry of Education and Research today announced an additional funding of EUR 50 million to support the vital work of the Global Antibiotic Research & Development Partnership (GARDP) over the next five years (2023-2027). Germany’s contribution will allow GARDP to develop new treatments for drug-resistant infections and ensure they are available for every person who needs them. The announcement was made on the occasion of the World Health Summit in Berlin.
Further reading: GARDP
Author(s): GARDP
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
